Skip to content

Static Helical Screw Locking of Pertrochanteric Femur Fractures Using the TFN-A

Pertrochanteric Fracture

The study will investigate the shortening and collapse of pertrochanteric fractures following surgical management with the TFN-Advanced nailing system. The focus will be on comparing radiographic assessments of nails which have been statically locked versus dynamically locked. This is a randomized control study with the initial invention being randomized to either statically locking or dynamically locking. For a two-month period, all eligible patients will receive the randomized allocated treatment, then treatment will switch to the alternate treatment for the next two months and will continue to alternate treatments for two-month periods until study enrollment has completed.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Patients \>18 years of age
* AO/OTA 31-A fractures who the surgeon deems eligible for treatment with a cephalomedullary nail
* Open and closed fractures
* Ambulatory prior to injury (with or without walking aides)
* Native (non-fractured, no implant) contralateral hip
* Willing and able to sign consent (substitute decision maker)

Exclusion Criteria:

* Contralateral hip fracture or hip arthroplasty
* Fracture not amenable to treatment with a cephalomedullary nail
* Non-ambulatory patient
* Fractures \>14 days (time of injury to OR)
* Bilateral pertrochanteric hip fractures
* Non-unions
* Pathologic fractures
* Periprosthetic fractures
* Patients with spinal injury
* Incarceration
* Pregnancy
* Limited life expectancy due to significant medical co-morbidities or medical contra-indications to surgery
* Likely problems, in the judgement of the investigators, with maintaining follow-up (i.e., patients with no fixed address, report a plan to move out of town, or intellectually challenged patients without adequate family support).

Lieu de l'étude

Royal Columbian Hospital/Fraser Health Authority
Royal Columbian Hospital/Fraser Health Authority
New Westminster, British Columbia
Canada

Contactez l'équipe d'étude

Primary Contact

Kyrsten Butterfield, BSc

[email protected]
604-553-3247
Étude parrainée par
Fraser Orthopaedic Research Society
Participants recherchés
Plus d'informations
ID de l'étude: NCT04851509